Amlodipine Besylate and Benazepril Hydrochloride
- Product NDC
- 70518-3030
- 11-digit product format
- 705183030
- Labeler code
- 70518
- Product ID
- 70518-3030_bc423600-b8c9-45fa-e053-2995a90a808c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Amlodipine Besylate and Benazepril Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA078466
- Marketing category
- ANDA
- Marketing start
- 2021-02-25
- Marketing end
- 0000-00-00
- Substance
- AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
- Active strength
- 5 mg/1; mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-3030-0 | 70518303000 | 90 CAPSULE in 1 BOTTLE, PLASTIC (70518-3030-0) | 90 capsule | 2021-02-25 | 0000-00-00 | No | No | Current |